Edition:
United Kingdom

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

1.04USD
6:27pm GMT
Change (% chg)

$-0.03 (-2.80%)
Prev Close
$1.07
Open
$1.05
Day's High
$1.06
Day's Low
$1.04
Volume
41,337
Avg. Vol
102,536
52-wk High
$1.80
52-wk Low
$0.43

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 1 0.09 0.09 0.09 --
Quarter Ending Sep-19 1 0.09 0.09 0.09 --
Year Ending Mar-19 3 0.00 0.00 0.00 3.24
Year Ending Mar-20 2 0.64 1.28 0.00 0.00
Earnings (per share)
Quarter Ending Jun-19 1 -0.10 -0.10 -0.10 --
Quarter Ending Sep-19 1 -0.07 -0.07 -0.07 --
Year Ending Mar-19 3 -0.53 -0.21 -0.84 -0.79
Year Ending Mar-20 2 -0.21 -0.17 -0.25 -0.86
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.30 32.54
P/E High - Last 5 Yrs. -- 43.23 48.15
P/E Low - Last 5 Yrs. -- 22.71 23.42
Beta -- 0.86 0.87
Price to Sales (TTM) -- 6.59 8.39
Price to Book (MRQ) -- 5.12 5.27
Price to Tangible Book (MRQ) -- 5.84 6.74
Price to Cash Flow (TTM) -- 23.07 24.12
% Owned Institutions -- 0.87 1.65

Dividends

  Company industry sector
Dividend Yield -- 1.43 1.35
Dividend Yield - 5 Year Avg -- 1.45 1.37
Dividend 5 Year Growth Rate -- 3.99 4.70
Payout Ratio(TTM) -- 42.18 39.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.43 13.45
Sales (TTM) vs TTM 1 Yr. Ago -- 6.61 8.02
Sales - 5 Yr. Growth Rate -- 10.48 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 45.67 47.68
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.47
Capital Spending - 5 Yr. Growth Rate -- 15.26 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.07 2.18
Current Ratio (MRQ) -- 2.87 2.98
LT Debt to Equity (MRQ) -- 8.87 11.35
Total Debt to Equity (MRQ) -- 12.87 16.02
Interest Coverage (TTM) -- 32.47 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 52.10 52.41
Gross Margin - 5 Yr. Avg. -- 49.66 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.26 12.43
Operating Margin (TTM) -- 13.53 5.77
Operating Margin - 5 Yr. Avg. -- 13.69 8.02
Pre-Tax Margin (TTM) -- 11.90 4.80
Pre-Tax Margin - 5 Yr. Avg. -- 14.11 8.31
Net Profit Margin (TTM) -- 8.81 1.53
Net Profit Margin - 5 Yr. Avg. -- 10.60 4.72
Effective Tax Rate (TTM) -- 22.12 22.13
Effective Tax Rate - 5 Yr. Avg. -- 22.26 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 928,329,132 820,307,541
Net Income/Employee (TTM) -- 105,132,015 92,854,576
Receivable Turnover (TTM) -- 5.84 5.82
Inventory Turnover (TTM) -- 2.57 3.41
Asset Turnover (TTM) -- 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 10.98 10.60
Return on Assets - 5 Yr. Avg. -- 12.41 11.78
Return on Investment (TTM) -- 14.23 13.82
Return on Investment - 5 Yr. Avg. -- 16.18 15.32
Return on Equity (TTM) -- 15.46 15.25
Return on Equity - 5 Yr. Avg. -- 17.07 16.41
Note: Units in Millions of US Dollars

Performance for Acasti Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.